Literature DB >> 23847308

Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes.

Monique S Roy1, Malvin N Janal, Juan Crosby, Robert Donnelly.   

Abstract

PURPOSE: We examined whether baseline plasma levels of markers of inflammation and endothelial dysfunction are associated with the incidence of diabetic retinopathy (DR) in African Americans with type 1 insulin-dependent diabetes mellitus (T1DM).
METHODS: At baseline and follow-up examinations, detailed ocular examination, structured clinical interview, venous blood specimens, and masked grading of seven standard field retinal photographs were obtained. Baseline plasma levels of 28 inflammatory biomarkers, measured using multiplex bead analysis system, were measured in the participants.
RESULTS: After adjusting for age, glycemic control, and other potential confounders, baseline plasma levels of E-selectin were associated significantly with progression of DR, E-selectin and tumor necrosis factor-α (TNF-α) levels with incidence of proliferative DR (PDR), and soluble intercellular adhesion molecule-1 (sICAM-1) and TNF-α levels with incidence of macular edema (ME).
CONCLUSIONS: In African Americans with T1DM, inflammation and endothelial dysfunction precede the development of DR, thus supporting the notion that inflammation may influence progression/incidence of disease.

Entities:  

Keywords:  African Americans; biomarkers; diabetic retinopathy; incidence; inflammation

Mesh:

Substances:

Year:  2013        PMID: 23847308      PMCID: PMC3743457          DOI: 10.1167/iovs.13-12212

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  66 in total

1.  Is diabetic retinopathy an inflammatory disease?

Authors:  A P Adamis
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy.

Authors:  Jinzi Zhou; Shuhong Wang; Xiaobo Xia
Journal:  Curr Eye Res       Date:  2012-03-12       Impact factor: 2.424

3.  Interferon-induced protein 10 and interleukin 8. C-X-C chemokines present in proliferative diabetic retinopathy.

Authors:  S G Elner; R Strieter; Z M Bian; S Kunkel; L Mokhtarzaden; M Johnson; N Lukacs; V M Elner
Journal:  Arch Ophthalmol       Date:  1998-12

4.  Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.

Authors:  Ahmed M Abu El-Asrar; Sofie Struyf; Dustan Kangave; Karel Geboes; Jo Van Damme
Journal:  Eur Cytokine Netw       Date:  2006-09       Impact factor: 2.737

5.  Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.

Authors:  Hiroshi Tamura; Kazuaki Miyamoto; Junichi Kiryu; Shinsuke Miyahara; Hideto Katsuta; Fumitaka Hirose; Kunihiro Musashi; Nagahisa Yoshimura
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-04       Impact factor: 4.799

6.  Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study.

Authors:  M T Schram; N Chaturvedi; C G Schalkwijk; J H Fuller; C D A Stehouwer
Journal:  Diabetologia       Date:  2005-02-04       Impact factor: 10.122

Review 7.  Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.

Authors:  K J Tracey; A Cerami
Journal:  Annu Rev Med       Date:  1994       Impact factor: 13.739

8.  Upregulation of P-selectin and intercellular adhesion molecule-1 after retinal ischemia-reperfusion injury.

Authors:  Akiko Nishiwaki; Takashi Ueda; Shinya Ugawa; Shoichi Shimada; Yuichiro Ogura
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

9.  Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells.

Authors:  Weiqin Chen; Donald B Jump; Maria B Grant; Walter J Esselman; Julia V Busik
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

10.  The Hypertension Prevention Trial: assessment of the quality of blood pressure measurements.

Authors:  P L Canner; N O Borhani; A Oberman; J Cutler; R J Prineas; H Langford; F J Hooper
Journal:  Am J Epidemiol       Date:  1991-08-15       Impact factor: 4.897

View more
  13 in total

Review 1.  Future opportunities in diabetic retinopathy research.

Authors:  Thomas W Gardner; Emily Y Chew
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-04       Impact factor: 3.243

2.  Retinol binding protein 3 as biomarker for diabetic retinopathy.

Authors:  Ward Fickweiler; Lloyd P Aiello; Jennifer K Sun; George L King
Journal:  Ann Transl Med       Date:  2019-11

Review 3.  Biomarkers of Diabetic Retinopathy.

Authors:  Daniel Shu Wei Ting; Kara-Anne Tan; Val Phua; Gavin Siew Wei Tan; Chee Wai Wong; Tien Yin Wong
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

4.  TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy.

Authors:  C Costagliola; V Romano; M De Tollis; F Aceto; R dell'Omo; M R Romano; C Pedicino; F Semeraro
Journal:  Mediators Inflamm       Date:  2013-10-23       Impact factor: 4.711

5.  Monosodium Urate Contributes to Retinal Inflammation and Progression of Diabetic Retinopathy.

Authors:  Menaka C Thounaojam; Annalisa Montemari; Folami L Powell; Prerana Malla; Diana R Gutsaeva; Alessandra Bachettoni; Guido Ripandelli; Andrea Repossi; Amany Tawfik; Pamela M Martin; Francesco Facchiano; Manuela Bartoli
Journal:  Diabetes       Date:  2019-02-06       Impact factor: 9.461

6.  OMICs approaches-assisted identification of macrophages-derived MIP-1γ as the therapeutic target of botanical products TNTL in diabetic retinopathy.

Authors:  Ning Wang; Cheng Zhang; Yu Xu; Sha Li; Hor-Yue Tan; Wen Xia; Yibin Feng
Journal:  Cell Commun Signal       Date:  2019-07-22       Impact factor: 5.712

Review 7.  Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology.

Authors:  Olga Simó-Servat; Rafael Simó; Cristina Hernández
Journal:  J Diabetes Res       Date:  2016-06-08       Impact factor: 4.011

8.  Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditions.

Authors:  Undurti N Das
Journal:  Arch Med Sci       Date:  2016-08-25       Impact factor: 3.318

Review 9.  Inflammatory and angiogenic biomarkers in diabetic retinopathy.

Authors:  Snježana Kaštelan; Ivana Orešković; Filip Bišćan; Helena Kaštelan; Antonela Gverović Antunica
Journal:  Biochem Med (Zagreb)       Date:  2020-08-05       Impact factor: 2.313

10.  Acute phase ketosis-prone atypical diabetes is associated with a pro-inflammatory profile: a case-control study in a sub-Saharan African population.

Authors:  Eric Lontchi-Yimagou; Philippe Boudou; Jean Louis Nguewa; Jean Jacques Noubiap; Vicky Kamwa; Eric Noel Djahmeni; Babara Atogho-Tiedeu; Marcel Azabji-Kenfack; Martine Etoa; Gaelle Lemdjo; Mesmin Yefou Dehayem; Jean Claude Mbanya; Jean-Francois Gautier; Eugène Sobngwi
Journal:  J Diabetes Metab Disord       Date:  2018-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.